The 2019 Sternfels Prize for Drug Safety Discoveries has opened submissions for its upcoming competition.
According to the competition’s website, the prize is awarded to “the most novel, clinically relevant, and testable idea to reduce life threatening drug-drug, drug-disease or pharmacogenomic interactions.”
Submissions must be the applicant’s own work.
The winning submission will receive a $35,000 prize.
“The Sternfels Prize was created to reduce the risk associated with the real-world use of pharmaceuticals,” the website states. “The purpose of the prize is to incentivize pharmacologists, pharmacists, medical practitioners, academics, and students to think about ways to reduce the real world risks patients face from polypharmacy, interacting co-morbidities, and genetic variations.”
Deadline for submissions is Jan. 31. Entries submitted by Dec. 15 will receive “critical feedback” and have the opportunity to resubmit.
To find out more about the competition, click here.